Atlas FDA

HYDRELLE

FDA premarket approval P050033/S007 · decided 2009-06-01

Approval details

PMA number
P050033
Supplement
S007
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
HYDRELLE
Generic name
Implant, dermal, for aesthetic use
Applicant
Anika Therapeutics, Inc.
Date received
2009-05-15
Decision date
2009-06-01
Days to decision
17 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Beford, MA
Statement
APPROVAL FOR A CHANGE IN THE DEVICE NAME FROM ELEVESS TO HYDRELLE.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Integrity™ Implant (K250997)Anika Therapeutics, Inc.2025-06-17
Tactoset® Injectable Bone Substitute (K231968)Anika Therapeutics, Inc.2023-12-20
Integrity Implant (K223538)Anika Therapeutics, Inc.2023-08-17
Integrity™ Bone Staple Fixation System (K223860)Anika Therapeutics, Inc.2023-05-22
Anika Tissue Tack Fixation System (K222487)Anika Therapeutics, Inc.2023-05-08
Tactoset (K223915)Anika Therapeutics, Inc.2023-03-29
Tactoset Injectable Bone Substitute (K212083)Anika Therapeutics, Inc.2021-08-31
SCS 17-01 (K190956)Anika Therapeutics, Inc.2020-01-30